Search

Your search keyword '"Kai, Hirofumi"' showing total 750 results

Search Constraints

Start Over You searched for: Author "Kai, Hirofumi" Remove constraint Author: "Kai, Hirofumi"
750 results on '"Kai, Hirofumi"'

Search Results

2. Correction: The 2019 and 2021 International workshops on Alport syndrome

4. The 2019 and 2021 International Workshops on Alport Syndrome

6. Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH

7. T3 Intratracheal Therapy Alleviates Pulmonary Pathology in an Elastase-Induced Emphysema-Dominant COPD Mouse Model

10. Metformin ameliorates the severity of experimental Alport syndrome

12. TALENs Facilitate Single-step Seamless SDF Correction of F508del CFTR in Airway Epithelial Submucosal Gland Cell-derived CF-iPSCs

15. T 3 Intratracheal Therapy Alleviates Pulmonary Pathology in an Elastase-Induced Emphysema-Dominant COPD Mouse Model.

19. CyclosporinA Derivative as Therapeutic Candidate for Alport Syndrome by Inducing Mutant Type IV Collagen Secretion

20. Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5

22. Melinjo seed extract increases adiponectin multimerization in physiological and pathological conditions

23. Hydrogen bonds connecting the N-terminal region and the DE loop stabilize the monomeric structure of transthyretin.

24. Correction: The 2019 and 2021 International workshops on Alport syndrome

34. Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates Progressive Phenotype in Alport Syndrome Mouse Model

35. Seamless Gene Correction in the Human Cystic Fibrosis Transmembrane Conductance Regulator Locus by Vector Replacement and Vector Insertion Events

37. Seamless Gene Correction in the Human Cystic Fibrosis Transmembrane Conductance Regulator Locus by Vector Replacement and Vector Insertion Events

43. Efficacy of Keap1-Nrf2 protein-protein interaction inhibitor for glomerulosclerosis in mouse model of chronic kidney disease

49. Differential mode of cholesterol inclusion with 2‐hydroxypropyl‐cyclodextrins increases safety margin in treatment of Niemann‐Pick disease type C

50. Activation of heat shock response improves biomarkers of NAFLD in patients with metabolic diseases

Catalog

Books, media, physical & digital resources